BridgeBio Oncology Therapeutics Inc. logo

BridgeBio Oncology Therapeutics Inc.

BBOT | NASDAQ
Chart Builder DCF Calculator
$4.67
+$0.01 (+0.21%)
Sep 22, 2026, 10:37 AM ET · Market open
TTM
Period Ending
Q2 2026
Jun 29, 2026
Q1 2026
Mar 30, 2026
Q4 2025
Dec 30, 2025
Q3 2025
Sep 29, 2025
Q2 2025
Jun 29, 2025
Q1 2025
Mar 30, 2025
Q4 2024
Dec 30, 2024
Q3 2024
Sep 29, 2024
Q2 2024
Jun 29, 2024
Q1 2024
Mar 30, 2024
Q4 2023
Dec 30, 2023
Q3 2023
Sep 29, 2023
Cash & Equivalents
54.06M 52.66M 373.69M 408.74M 31.52M 26.22M 1.7M 1.79M 1.81M 1.84M n/a n/a
Short-Term Investments
171.65M 199.62M 51.77M 59.54M 99.88M 109.5M n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a 136.75M 132K n/a n/a n/a 192.45M 190.2M 187.65M 185.21M n/a n/a
Other Long-Term Assets
131.35M 11.24M 18.8M 5.52M 5.46M 5.15M 25.13K 87.59K 150.05K 212.51K 332.89K 144.58K
Receivables
n/a 146K 386K 226K 1.08M 40K n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
16.67M 14.08M -386K 7.5M 5.58M 5.57M n/a n/a n/a n/a n/a n/a
Total Current Assets
242.38M 266.5M 425.46M 476.01M 142.35M 141.33M 1.95M 2.04M 2.08M 2.11M n/a n/a
Property-Plant & Equipment
2.98M 3.16M 3.29M 3.27M 3.45M 3.36M n/a n/a n/a n/a n/a n/a
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
134.33M 151.14M 22.92M 8.78M 8.91M 8.51M 192.47M 190.29M 187.8M 185.42M 332.89K 144.58K
Total Assets
376.71M 417.65M 448.38M 484.79M 151.25M 149.84M 194.42M 192.33M 189.87M 187.53M 332.89K 144.58K
Account Payables
6.73M 12.09M 1.37M 3.65M 2.2M 3.65M n/a n/a n/a n/a n/a n/a
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
554K 538K 522K n/a n/a n/a n/a n/a n/a n/a 70.1K 43.4K
Other Current Liabilities
51.08M 28.61M 27.4M 4.49M 2.74M 5.73M n/a 126.69K n/a n/a n/a n/a
Total Current Liabilities
51.63M 43.26M 35.04M 35.71M 27.25M 24.06M 187.52K 126.69K 79.14K 23.33K 396.46K 166.46K
Long-Term Debt
1.96M n/a 2.24M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a 349.22M 323.17M 5.52M n/a n/a n/a n/a n/a
Total Long-Term Liabilities
1.96M 2.11M 2.24M 2.38M 351.74M 325.81M 5.52M 5.52M 5.52M 5.52M n/a n/a
Total Liabilities
53.59M 45.37M 37.29M 38.09M 378.99M 349.87M 5.71M 5.65M 5.6M 5.54M 396.46K 166.46K
Total Debt
2.51M 2.64M 2.77M 2.89M 2.83M 2.65M n/a n/a n/a n/a 70.1K 43.4K
Book Value
323.11M 372.28M 411.1M 446.7M -227.73M -200.03M 188.72M 186.69M 184.28M 181.99M -63.57K -21.88K
Book Value Per Share
4.04K 11.95 13.20 19 -9.69 -8.51 11.34 7.94 7.84 8.27 0 0
Common Stock
8K 8K 8K 8K n/a n/a 192.45M 190.2M 187.65M 185.21M 460 288
Retained Earnings
-455.13M -398.67M -356.57M -317.77M -273.01M -244.58M -3.73M -3.52M -3.37M -3.22M -88.57K -46.88K
Comprehensive Income
-959K -981K 16K 36K 51K 191K n/a n/a n/a n/a n/a n/a
Shareholders Equity
323.11M 372.28M 411.1M 446.7M -227.73M -200.03M 188.72M 186.69M 184.28M 181.99M -63.57K -21.88K
Total Investments
171.65M 336.37M 51.91M 59.54M 99.88M 109.5M 192.45M 190.2M 187.65M 185.21M n/a n/a

© 2026 bestshares.com. All rights reserved.